12 Deals of Christmas
AMBER ALERT – Share to help find missing 1-year-old

Yale Cancer Center develops new flu vaccination strategy

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

NEW HAVEN — Researchers at the Yale Cancer Center have developed a new vaccination strategy that they say greatly reduces the risk of potentially life-threatening flu infections in cancer patients that are the most vulnerable.

Studies have shown that patients with cancers of the immune system are extremely susceptible to common infections and a one-time flu shot is not the remedy.

Yale’s new strategy consists of offering patients a high-dose flu vaccine followed by a second high-dose booster shot one month later.

Dr. Andrew Branagan says the vaccination strategy lowered the infection rate among patients to 6 percent and it improved protection against all flu strains covered by the vaccine in 66 percent of patients.

Yale’s findings were presented Sunday at the American Society of Hematology’s annual meeting in Orlando, Florida.


Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.